(Date:11/21/2008)... and deadly diseaseits cause remains a mysteryswep...ming with citizens, soldiers and refugees of the w...ts filled with corpses, social order broke down. O...ce and Athens lost a third of its population. It l...eginning of the end of the Golden Age of Greece. ...
(Date:11/21/2008)...PRNewswire/ -- For the second year in a row and ...althcare Worldwide,s agency network won more creat...nd annual international RX Club Show. , , ...n a total of 59 RX Club Awards of Excellence, incl...althcare Worldwide agencies include Caudex Medical...
(Date:11/21/2008)...1 Symmetry Medical Inc. ...products to the global orthopedic device industry ...ian S. Moore, President and Chief Executive Office...ef Financial Officer, are scheduled to present at ...ce at The New York Palace Hotel on Wednesday, Dece...
(Date:11/21/2008)...cco use is more prevalent and smoking cessation le...eractivity Disorder (A.D.H.D.) In a study of smok...oms, those who exhibited elevated hyperactivity an... lower quit rates after 8 weeks than those with in...H.D. symptoms. The study, now available online in...
Breaking Medicine News(10 mins):Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4Health News:Ability to quit smoking may depend on ADHD symptoms, Columbia researchers find 2(Date:11/20/2008)... Duska Therapeutics,Inc...t it has submitted its,pivotal Phase 3 ATPace cli...rotocol Assessment (SPA) procedure with the U.S. F...ct to securing an agreement with the FDA, Duska in...lind, placebo-controlled and randomized Phase 3,c...
(Date:11/19/2008)...Newswire/ -- Posit Science Corporation,researcher...r Neuroscience,Annual Conference in Washington, D...y benefit Baby Boomers. The computerized brain pl...aptive exercises that target auditory and,languag...neralized,improvements in cognition by improving ...
(Date:11/19/2008)...ewswire/ -- Isogen, a contract development and,ma...y announced the first,phase launch of its contrac...cifically address the process, facility and capaci...on highly-niched, low-volume clinical and,early-s... Companies can invest over $100 million and ...
(Date:11/18/2008)...RNewswire-USNewswire/ -- Forty-two leading U. S. s...ational forum to consider cutting-edge innovations...nal economy from outbreaks of dangerous zoonotic d... Among those innovations: , , , , ...ble that detects highly contagious and dangerous z...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Isogen Launches Major New Facility to Address Global Biopharma Demand 242 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Flagship Global Health Announces Annual Meeting 14647 152 minority scientists receive travel fellowships to Experimental Biology 2008 14643 152 minority scientists receive travel fellowships to Experimental Biology 2008 14643 252 minority scientists receive travel fellowships to Experimental Biology 2008 14643 3NeurogesX to Report Fourth Quarter and Year End 2007 Financial Results 4059 1NeurogesX to Report Fourth Quarter and Year End 2007 Financial Results 4059 2NeurogesX to Report Fourth Quarter and Year End 2007 Financial Results 4059 3CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 1CVS Caremark Corp to Pay 2436 7 Million to U S 23 States 26 D C to Settle Medicaid Prescription Drug Fraud Allegations 14636 2... WIRE)--Apr 25, 2007 - Geron,Corporation (Nasdaq:G...e role of telomerase and telomeres in cancer at th... (AACR) Annual Meeting in,Los Angeles. There were ...omerase biology reflecting the growing body of evi... universal cancer,target for drug and vaccine deve...
...)--Apr 25, 2007 - Reata,Pharmaceuticals, Inc. toda...vering the company,s Synthetic Triterpenoid progra...l "Nature Reviews,Cancer.", The article, "Triterpe...the prevention and treatment of cancer," by resear...Dartmouth Medical,School Karen T. Liby, Mark M. Yo...
Other Medicine Technology:Telomerase Presentations at the AACR 2007 Annual Meeting 2Telomerase Presentations at the AACR 2007 Annual Meeting 3Telomerase Presentations at the AACR 2007 Annual Meeting 4Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 2Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 3Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer 4The Bledsoe M-Brace Ankle Support reduces ankle swelling while boosting the patient's confidence when its time to get back in the game. The M-Brace is available in two models the Air M-Brace or the
The Bledsoe PTB Boot is designed as a flexible and attractive alternative to casting for the mid-tibia or fibula to mid-foot area while providing patella tendon bearing support. The Bledsoe EZ Set PT
The Bledsoe Mid-Calf Boot is a shorter and lighter version of our regular boot designed for second degree ankle sprains, toe and forefoot contusion, and incision protection. The Bledsoe EZ Set Mid-Ca
The Bledsoe LC & LC2 Boots are our most economical, lightweight walkers. The LC & LC2 are designed to enhance mobility for sprains, strains, and some types of fractures.
Medicine Products: